argenx SE
pemphigus registrational trial focused on fast onset and steroid sparing address | argenx SE
Company
Deck Type
Sector
Industry
Deck date
October 2021
Slide
9 of 20
Similar slides by argenx SE
See diffirences between slides (animation)
Investor Presentation
December 2023
address | argenx SE
Investor Presentation
November 2023
pemphigus address trial topline data expected around | argenx SE
Results
October 2023
pemphigus address trial | argenx SE
Investor Presentation
August 2023
pemphigus address trial focus on fast onset and steroid sparing extension study | argenx SE
Related slides by other companies
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
Alkermes
Investor Presentation
October 2023
deliberate and focused development program | Alkermes
Theravance Biopharma
Investor Conference
November 2022
new study in patients with cypress | Theravance Biopharma
Mink Therapeutics
IPO
October 2021
phase clinical trial focused in solid tumors | Mink Therapeutics
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io